A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis

Clinical trial NCT01045018 · COMPLETED

Trial details

NCT number: NCT01045018
Sponsor: EMET Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mild to Moderate Ulcerative Colitis

Start date: 2008-01-01
Primary completion: 2009-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.